Markets

IXI ETF Offers Defense but at a Premium Price

IXI's low beta offers shelter from market swings, but a 23.8x earnings multiple means investors are paying a premium for that safety.

Daniel Marsh · · · 4 min read · 6 views
IXI ETF Offers Defense but at a Premium Price
Mentioned in this article
COST $893.74 -0.84% PG $147.02 +0.24% WMT $107.50 -0.55%

Australian investors seeking refuge after the Federal Reserve's latest rate hike might consider the iShares Global Consumer Staples ETF (ASX:IXI), but the rationale goes beyond the typical defensive play. While IXI's portfolio has shown significantly less volatility than the broader equity market over the past three years, it remains an equity fund, and its current valuation leaves little margin for error.

On Thursday, September 17, IXI traded at A$94.00 by 11:46 a.m. AEST, a marginal 0.15% dip from the previous close of A$94.14. This modest movement followed the Fed's 25-basis-point rate increase, which brought the target range to 3.75%-4.00%. The key question for investors is whether IXI can cushion a broader selloff without demanding an excessive premium for that stability.

The Defensive Case Is Quantifiable

BlackRock's Australian fund documentation states that IXI aims to replicate the S&P Global 1200 Consumer Staples Sector Capped Index, charging a management fee of 0.41% annually—that's A$41 per A$10,000 invested, excluding trading costs and tracking differences. The fund is marketed to investors with a minimum five-year horizon and a medium-to-high risk profile, a description that carries more weight than the comforting 'staples' label.

The Australian-listed fund holds a single security: the U.S.-listed iShares Global Consumer Staples ETF (NYSEARCA:KXI). As of September 15, BlackRock reported 92 underlying holdings, a three-year equity beta of 0.36 as of August 31, and a trailing yield of 2.35%. A beta below one indicates the portfolio has historically been less volatile than the equity market, but it does not guarantee protection against losses or ensure gains during a downturn.

Revenue Defense from Everyday Essentials

The defensive nature stems from the fund's focus on consumer staples—products like food, beverages, cleaning supplies, and personal care items that remain in demand even when discretionary spending contracts. As of September 15, nearly half of KXI's market value was allocated to food, beverages, and tobacco, with about 30% in staples distribution and retail, and 21% in household and personal products. This composition tends to make revenue and cash flows less cyclical compared to sectors like technology, mining, or discretionary retail.

What IXI Actually Holds

IXI is not an Australian consumer-staples portfolio. The underlying fund had 59.37% of its market value in U.S.-domiciled companies as of September 15, while Australia accounted for just 1.52%. Its largest recent positions included Walmart, Costco, and Procter & Gamble. For Australian investors, returns are therefore influenced by global staples shares, foreign-exchange movements, and the local ASX price.

Concentration risk also lurks beneath the 92-stock headline. BlackRock's latest fact sheet revealed that the ten largest positions represent about half of the portfolio, with Walmart and Costco alone accounting for roughly 17%. While these are robust businesses, paying a premium for perceived safety can become a risk in itself if a retailer's margins, membership growth, or valuation face a reset.

The Valuation Concern

That risk is evident in the multiple. KXI's weighted price-to-earnings ratio stood at 23.80 on September 15. While this figure is not a forecast and may not be directly comparable to every broad-market index, it underscores that IXI is not a bargain-bin hedge. Investors are accepting a modest trailing yield and a full earnings multiple in exchange for historically lower sensitivity to market swings.

The Case Against Buying IXI Now

The counterargument is that higher interest rates do not automatically favor consumer staples. Expensive defensive stocks can underperform when bond yields rise, as their steady cash flows compete with improved fixed-income returns. Additionally, input-cost inflation can squeeze margins before companies can pass on price increases. The Fed noted that inflation remains elevated, making both pressures relevant.

Local trading dynamics also warrant attention. One delayed-price service recorded only 100 IXI units changing hands on September 16. While this may not capture all venues or late adjustments, it suggests that a market order could suffer from a wide bid-ask spread. A limit order near the indicative value is a more prudent approach to avoid turning a defensive allocation into an unnecessary entry cost.

Finally, if KXI's beta were to rise during the next equity selloff, the defensive premise would weaken. Even with a low beta, earnings must support a multiple near 24 times, and the Australian unit must track its underlying value without persistent spreads. IXI can reduce portfolio cyclicality, but it cannot transform equities into cash.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →